Novartis AG
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Short-Term Financial Debt & Current Portion Due Within by Year
Short-Term Financial Debt & Current Portion Due Within 1 Year (current-debt) ($M)
Novartis Short-Term Financial Debt & Current Portion Due Within: $5,602M in FY2025, down 31.9% from a year earlier. That is the lowest of the 8 years on record here.
Where the FY2025 figure comes from
“|| Financial debts and derivative financial instruments | 9 650 | 5 602”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Postgres DB + Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Short-Term Financial Debt & Current Portion Due Within 1 Year (current-debt) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5,602 | -31.9% | Novartis Form 6-K (0001114448-26-000014) ↗ |
| FY2024 | Dec 31, 2024 | 8,232 | +33.3% | Novartis Form 6-K (0001114448-25-000003) ↗ |
| FY2023 | Dec 31, 2023 | 6,175 | +4.1% | Novartis Form 6-K (0001370368-24-000022) ↗ |
| FY2022 | Dec 31, 2022 | 5,931 | -5.8% | Novartis Form 6-K (0001370368-23-000068) ↗ |
| FY2021 | Dec 31, 2021 | 6,295 | -35.7% | Novartis Form 6-K (0001370368-22-000077) ↗ |
| FY2020 | Dec 31, 2020 | 9,785 | +39.2% | Novartis Form 6-K (0001370368-21-000072) ↗ |
| FY2019 | Dec 31, 2019 | 7,031 | -27.4% | Novartis Form 6-K (0001370368-20-000086) ↗ |
| FY2018 | Dec 31, 2018 | 9,678 | – | Novartis Form 6-K (0001370368-19-000062) ↗ |
Cite this data
StockData. (2026). Novartis Short-Term Financial Debt & Current Portion Due Within ($M), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-curr-debt
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.